Annika de Jong
kathrynmoorelab.com
0000-0001-6124-535X
NYU Langone Health
11 papers found
Refreshing results…
Small interfering RNA–mediated allele-selective silencing of von Willebrand factor in vitro and in vivo
Identification of von Willebrand factor D4 domain mutations in patients of Afro‐Caribbean descent: In vitro characterization
Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNA
Endothelial characteristics in healthy endothelial colony forming cells; generating a robust and valid ex vivo model for vascular disease
Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms
Use of “C9/11 Mismatch” Control siRNA Reveals Sequence-Related Off-Target Effect on Coagulation of an siRNA Targeting Mouse Coagulation Factor XII
Variability of von Willebrand factor‐related parameters in endothelial colony forming cells
Correction of a dominant-negative von Willebrand factor multimerization defect by small interfering RNA-mediated allele-specific inhibition of mutant von Willebrand factor
Von Willebrand disease mutation spectrum and associated mutation mechanisms
Developments in the diagnostic procedures for von Willebrand disease
Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4
Missing publications? Search for publications with a matching author name.